From Virtual to Real | Unleashing Potential in Stroke Rehabilitation with VR

According to the most recent industry analysis from Future Market Insights, the Global VR Stroke Rehabilitation Market Size was valued at approximately US$ 144.9 Billion in 2022 and is predicted to rise at a CAGR of 9.2% over the forecast period, reaching an estimated valuation of US$ 376.0 Billion in 2033.

Given the frequency of brain damage in the population and the need for innovative rehabilitation approaches, it is critical to investigate the possibilities offered by cutting-edge technology.

When compared to real-world tasks, virtual reality (VR) has the potential to support current rehabilitation procedures by providing new opportunities for learning, responding to, and accomplishing activities in less complex ways that involve a simplified cognitive load, greater repetition, and progressive training.

Physical exercise and cognitive training can be used independently or together, depending on the therapeutic goal. VR enables the delivery of finely calibrated multimodal stimuli for information feedback or errorless learning methodologies in this regard.

Consumers and vendors are collaborating to create cutting-edge products that increase sales and earnings for both parties, allowing organisations and manufacturers to prosper and grow their operations through creative procurement methods. They employ innovative techniques and take an integrated approach to product development by incorporating a variety of approaches into their operations.

While non-invasive brain stimulation (NIBS) can change the neurophysiology that underpins cognitive functioning, virtual reality (VR) provides a controlled and appealing environment that can be tailored to the patient's specific demands. Many studies have suggested that combining these technologies may be more effective than using them separately for this purpose.

It has been used to treat spider phobia, induce embodiment for an artificial hand, and to intervene with a diverse group of people, including healthy adults, post-stroke patients, and children with cerebral palsy.

Browse More@ https://www.futuremarketinsights.com/reports/vr-stroke-rehabilitation-market

Key Market Segments Covered in the VR Stroke Rehabilitation Industry Research

Patient Type:

  • Short Term Patients
  • Long Term Patients

Service Provider:

  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Homecare settings

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more